Xponance’s SkinHealth Systems SKIN Stock Holding History

Xponance’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,317	Closed	-$9.18K	–	1873
2026 Q1	$9.18K	Buy	+10,317	New	+$12.7K	﹤0.01%	1682

Other funds holding SKIN

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Xponance's SKIN Position: Q2 2026 in Review

Xponance sold out of SkinHealth Systems (SKIN) in Q2 2026, closing a stake of 10,317 shares — an estimated $9.18K sold.

Xponance first reported a position in SKIN in Q1 2026 and held it in 1 quarter. The position peaked at $9.18K in Q1 2026. 96 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

Xponance reported no remaining SkinHealth Systems position as of Q2 2026 after selling out during the quarter.
Xponance sold 10,317 SkinHealth Systems shares in Q2 2026, an estimated $9.18K.
Xponance first reported a position in SkinHealth Systems in Q1 2026 and held it in 1 quarter.
Xponance's SkinHealth Systems position peaked at $9.18K in Q1 2026.
96 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.